4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-16-138557
CIK 0001566373operating
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 8:49 PM ET
Size
7.6 KB
Accession
0001209191-16-138557
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-08-24$11.90/sh+1,550$18,445→ 37,300 total - Purchase
Common Stock
2016-08-24$12.00/sh+350$4,200→ 37,750 total - Purchase
Common Stock
2016-08-24$11.99/sh+100$1,199→ 37,400 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 8:49 PM ET
- Size
- 7.6 KB